Clinical Trial

Short-term gluCOCOrticoid in Adult STEROID-sensitive Nephrotic Syndrome: The COCO-ASTEROID Study

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study will compare a short-term course (12 week) glucocorticoid regimen with the Conventional 24-week regimen as originally proposed by KDIGO. The purpose of the study is to determine a short-term course (12 week) of glucocorticoid decreases the time to first relapse in adults presenting with steroid sensitive nephrotic syndrome.
Trial Details
NCT Number NCT07151456
Lead Sponsor First Affiliated Hospital of Wenzhou Medical University
Conditions Idiopathic Nephrotic Syndrome
Enrollment 224 participants
Start Date 2026-01
Primary Completion 2029-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-03